SYMBYAX

This brand name is authorized in Mexico, United States

Active ingredients

The drug SYMBYAX contains a combination of these active pharmaceutical ingredients (APIs):

1 Olanzapine UNII N7U69T4SZR - OLANZAPINE

Olanzapine is an antipsychotic, antimanic and mood stabilising agent that demonstrates a broad pharmacologic profile across a number of receptor systems. Read about Olanzapine

2 Fluoxetine UNII I9W7N6B1KJ - FLUOXETINE HYDROCHLORIDE

Fluoxetine is a selective inhibitor of serotonin reuptake, and this probably accounts for the mechanism of action. Fluoxetine has practically no affinity to other receptors such as α1, α2, and β-adrenergic; serotonergic; dopaminergic; histaminergic1; muscarinic; and GABA receptors. Read about Fluoxetine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SYMBYAX Capsule	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06CA03		N Nervous system → N06 Psychoanaleptics → N06C Psycholeptics and psychoanaleptics in combination → N06CA Antidepressants in combination with psycholeptics
Discover more medicines within N06CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 336M2004
Country: US	FDA, National Drug Code	Identifier(s): 0002-3230, 0002-3231, 0002-3233, 0002-3234